D. E. Shaw & Co., Inc. Zai Lab LTD Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 69,000 shares of ZLAB stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,000

Holding current value

$1.81 Million

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.25 - $24.14 $139,067 - $206,590	-8,558 Reduced 49.16%	8,849 $213,000
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $32,214 - $50,599	2,348 Added 15.59%	17,407 $301,000
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $240,191 - $403,581	15,059 New	15,059 $241,000
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $916,252 - $1.27 Million	-40,328 Reduced 74.66%	13,691 $332,000
Q2 2023 Aug 14, 2023	SELL	$25.3 - $39.67 $11,891 - $18,644	-470 Reduced 0.86%	54,019 $1.5 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $893,490 - $1.42 Million	29,576 Added 118.72%	54,489 $1.81 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $4,456 - $7,742	-200 Reduced 0.8%	24,913 $764,000
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $2.62 Million - $3.96 Million	-76,528 Reduced 75.29%	25,113 $859,000
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $1.23 Million - $2.65 Million	53,349 Added 110.47%	101,641 $3.53 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $12,774 - $29,624	460 Added 0.96%	48,292 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $8.24 Million - $15.8 Million	-150,181 Reduced 75.84%	47,832 $3.01 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $15.8 Million - $26.8 Million	150,280 Added 314.83%	198,013 $20.9 Million
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $17.1 Million - $24.6 Million	-136,499 Reduced 74.09%	47,733 $8.45 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $5.34 Million - $8.11 Million	-42,282 Reduced 18.67%	184,232 $24.6 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $4.03 Million - $6.65 Million	49,137 Added 27.7%	226,514 $30.7 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $7.51 Million - $9.17 Million	102,455 Added 136.75%	177,377 $14.8 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $3.07 Million - $5.19 Million	-62,925 Reduced 45.65%	74,922 $6.15 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $4.2 Million - $6.75 Million	107,373 Added 352.34%	137,847 $7.1 Million
Q4 2019 Feb 14, 2020	SELL	$29.79 - $43.06 $262,688 - $379,703	-8,818 Reduced 22.44%	30,474 $1.27 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $742,218 - $917,116	24,359 Added 163.12%	39,292 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $384,226 - $534,452	14,933 New	14,933 $521,000
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $543,716 - $899,041	-36,369 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $647,368 - $921,954	36,369 New	36,369 $708,000
Q1 2018 May 15, 2018	SELL	$20.05 - $26.96 $205,372 - $276,151	-10,243 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$21.23 - $34.09 $217,458 - $349,183	10,243	10,243 $217,000

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account